FR2679909B1 - Polypeptides aptes a induire in vivo des anticorps inhibant l'invasion de globules rouges par des merozouites de p. falciparum, produits apparentes et leur application comme vaccin. - Google Patents

Polypeptides aptes a induire in vivo des anticorps inhibant l'invasion de globules rouges par des merozouites de p. falciparum, produits apparentes et leur application comme vaccin.

Info

Publication number
FR2679909B1
FR2679909B1 FR9109771A FR9109771A FR2679909B1 FR 2679909 B1 FR2679909 B1 FR 2679909B1 FR 9109771 A FR9109771 A FR 9109771A FR 9109771 A FR9109771 A FR 9109771A FR 2679909 B1 FR2679909 B1 FR 2679909B1
Authority
FR
France
Prior art keywords
merozouites
falciparum
vaccines
invasion
inducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9109771A
Other languages
English (en)
Other versions
FR2679909A1 (fr
Inventor
Mattei Denise
Scherf Artur
Pereira Da Silva Luiz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9109771A priority Critical patent/FR2679909B1/fr
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Priority to CA002114223A priority patent/CA2114223A1/fr
Priority to PCT/FR1992/000763 priority patent/WO1993003057A1/fr
Priority to AU24427/92A priority patent/AU2442792A/en
Priority to JP5503341A priority patent/JPH06510527A/ja
Priority to PT100757A priority patent/PT100757A/pt
Priority to ZA925784A priority patent/ZA925784B/xx
Priority to EP92917738A priority patent/EP0602079A1/fr
Publication of FR2679909A1 publication Critical patent/FR2679909A1/fr
Application granted granted Critical
Publication of FR2679909B1 publication Critical patent/FR2679909B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR9109771A 1991-07-31 1991-07-31 Polypeptides aptes a induire in vivo des anticorps inhibant l'invasion de globules rouges par des merozouites de p. falciparum, produits apparentes et leur application comme vaccin. Expired - Fee Related FR2679909B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR9109771A FR2679909B1 (fr) 1991-07-31 1991-07-31 Polypeptides aptes a induire in vivo des anticorps inhibant l'invasion de globules rouges par des merozouites de p. falciparum, produits apparentes et leur application comme vaccin.
PCT/FR1992/000763 WO1993003057A1 (fr) 1991-07-31 1992-07-31 Polypeptides aptes a induire in vivo des anticorps eux-memes capables d'inhiber l'invasion de globules rouges par des merozoites de p.falciparum, produits apparentes et leur application a la production de compositions vaccinantes
AU24427/92A AU2442792A (en) 1991-07-31 1992-07-31 Polypeptides capable of (in vivo) induction of antibodies themselves capable of inhibiting the invasion of red blood corpuscles by merozoites of (p.falciparum), related products and their use in producing vaccine compositions
JP5503341A JPH06510527A (ja) 1991-07-31 1992-07-31 Ｐ．ｆａｌｃｉｐａｒｕｍのメロゾイトによる赤血球侵入を抑制することがそれ自体可能な抗体をｉｎ　ｖｉｖｏで誘導し得るポリペプチド、関連生成物及びワクチン組成物の製造のためのその適用
CA002114223A CA2114223A1 (fr) 1991-07-31 1992-07-31 Polypeptides aptes a induire in vivo des anticorps eux-memes capables d'inhiber l'invasion de globules rouges par des merozoites de p. falciparum, produits apparentes et leur application a la production de compositions vaccinantes
PT100757A PT100757A (pt) 1991-07-31 1992-07-31 Polipeptidos aptos para induzir "in vivo"anticorpos capazes de inibir a invasao de globulos vermelhos por merozoitos de "p.falciparum", produtos aparentados e sua aplicacao na producao de composicoes de vacinacao
ZA925784A ZA925784B (en) 1991-07-31 1992-07-31 Polypeptides capable of inducing antibodies in vivo themselves capable of inhibiting the invasion of red blood cells by merozoites of P. falciparum, related products and their use in the production of vaccine compositions.
EP92917738A EP0602079A1 (fr) 1991-07-31 1992-07-31 POLYPEPTIDES APTES A INDUIRE $i(IN VIVO) DES ANTICORPS EUX-MEMES CAPABLES D'INHIBER L'INVASION DE GLOBULES ROUGES PAR DES MEROZOITES DE $i(P.FALCIPARUM), PRODUITS APPARENTES ET LEUR APPLICATION A LA PRODUCTION DE COMPOSITIONS VACCINANTES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9109771A FR2679909B1 (fr) 1991-07-31 1991-07-31 Polypeptides aptes a induire in vivo des anticorps inhibant l'invasion de globules rouges par des merozouites de p. falciparum, produits apparentes et leur application comme vaccin.

Publications (2)

Publication Number Publication Date
FR2679909A1 FR2679909A1 (fr) 1993-02-05
FR2679909B1 true FR2679909B1 (fr) 1995-08-25

Family

ID=9415799

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9109771A Expired - Fee Related FR2679909B1 (fr) 1991-07-31 1991-07-31 Polypeptides aptes a induire in vivo des anticorps inhibant l'invasion de globules rouges par des merozouites de p. falciparum, produits apparentes et leur application comme vaccin.

Country Status (2)

Country Link
FR (1) FR2679909B1 (fr)
ZA (1) ZA925784B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2735478B1 (fr) 1995-06-13 1997-08-22 Pasteur Institut Molecules polypeptidiques de stade pre-erythrocytaire du paludisme

Also Published As

Publication number Publication date
FR2679909A1 (fr) 1993-02-05
ZA925784B (en) 1993-04-22

Similar Documents

Publication Publication Date Title
CA2149329A1 (fr) Utilisation d'anticorps hybrides et radioisotopiques diriges contre l'antigene de restriction de la differenciation des lymphocytes b humains pour le traitement du lymphome b
HK160995A (en) Complex compounds of bioflavonoids with phospholipids their preparation and use and pharmaceutical and cosmetic compositions containing them
IL112665A0 (en) 5-substituted derivatives of mycophenolic acid, their preparation and pharmaceutical compositions containing them
IT8719659A0 (it) Procedimento per la preparazione di collageno e prodotti cosi'ottenuto.
IL152659A (en) Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer
EP0419653A4 (en) Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
IL112664A0 (en) 4-amino derivatives of mycophenolic acid, their preparation and pharmaceutical compositions containing them
NZ230199A (en) Antibody drug conjugate, intermediates and pharmaceutical compositions
PT749317E (pt) Aplicacoes terapeuticas de produtos dimericos de proteinas bactericidas indutoras da permeabilidade
IL112667A0 (en) 6-substituted derivatives of mycophenolic acid, their preparation and pharmaceutical compositions containing them
IL138424A0 (en) Covalently reactive antigen analogs and pharmaceutical compositions containing the same
NZ309659A (en) Composition comprising LbeIF4A and/or LmeIF4A polypeptides (Leishmania antigen) and methods for enhancing immune responses
IT8948458A0 (it) Procedimento per la preparazione di vaccini capaci di generare non solo la risposta immune dei linfociti t helper,ma anche un'efficace risposta di linfociti t citotossici,e vaccini con queste caratteristiche
AU7242796A (en) Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
IL94558A0 (en) Conjugate immunogen for aids and vaccine and pharmaceutical compositions containing it
IT8703680A0 (it) Impianto per la tostatura di caffe'noccioline, arachidi e simili prodotti
WO1998039027A3 (fr) Antigenes de sialyl lewis uilises comme cibles en immunotherapie
IT9020020A0 (it) "n,n'-ditrimetossibenzoilpiperazine 2-sostituite, procedimento per la loro preparazione e composizioni terapeutiche che le contengono
FR2679909B1 (fr) Polypeptides aptes a induire in vivo des anticorps inhibant l'invasion de globules rouges par des merozouites de p. falciparum, produits apparentes et leur application comme vaccin.
WO2000001729A3 (fr) Peptides synthetiques et compositions pharmaceutiques les contenant, destines au diagnostic et au traitement du syndrome anti-phospholipides
IL112668A0 (en) 4-amino 6-substituted mycophenolic acid and derivatives thereof, their preparation and pharmaceutical compositions containing them
RU97105044A (ru) Штамм bifidobacterium adolescentis г17513, используемый для получения бифидосодержащих препаратов-эубиотиков и продуктов лечебно-диетического питания
EP0351876A3 (fr) Composition pour augmenter l'effet de vaccination
UA27055C2 (uk) Лікарський препарат імуhозаміhhої дії hа осhові клітиhhої суспеhзії та спосіб лікуваhhя сиhдрому hабутого імуhодефіциту (віл-іhфекції) з використаhhям цього препарату
FR2756564B1 (fr) Derives d'acide quinoleine-8-carboxylique, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
ST Notification of lapse